These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18559429)

  • 1. Galactose residues on the lipooligosaccharide of Moraxella catarrhalis 26404 form the epitope recognized by the bactericidal antiserum from conjugate vaccination.
    Yu S; Xie H; Datta A; Naidu N; Gu XX
    Infect Immun; 2008 Sep; 76(9):4251-8. PubMed ID: 18559429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the potential of conserved inner core oligosaccharide regions of Moraxella catarrhalis lipopolysaccharide as vaccine antigens: accessibility and functional activity of monoclonal antibodies and glycoconjugate derived sera.
    Cox AD; St Michael F; Cairns CM; Lacelle S; Filion AL; Neelamegan D; Wenzel CQ; Horan H; Richards JC
    Glycoconj J; 2011 May; 28(3-4):165-82. PubMed ID: 21590368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant lipooligosaccharide-based conjugate vaccine demonstrates a broad-spectrum effectiveness against Moraxella catarrhalis.
    Ren D; Yu S; Gao S; Peng D; Petralia RS; Muszynski A; Carlson RW; Robbins JB; Tsai CM; Lim DJ; Gu XX
    Vaccine; 2011 Jun; 29(25):4210-7. PubMed ID: 21501641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Moraxella catarrhalis lipooligosaccharide mutants to identify specific oligosaccharide epitopes recognized by human serum antibodies.
    Schwingel JM; Edwards KJ; Cox AD; Masoud H; Richards JC; St Michael F; Tekwe CD; Sethi S; Murphy TF; Campagnari AA
    Infect Immun; 2009 Oct; 77(10):4548-58. PubMed ID: 19651870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis.
    Yu S; Gu XX
    Infect Immun; 2005 May; 73(5):2790-6. PubMed ID: 15845482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological characterisation of truncated lipooligosaccharide-outer membrane protein based conjugate vaccine against Moraxella catarrhalis and nontypeable Haemophilus influenzae.
    Singh S; Wilson JC; Cripps AW; Massa H; Ozberk V; Grice ID; Peak IR
    Vaccine; 2020 Jan; 38(2):309-317. PubMed ID: 31668366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characteristics of a protective monoclonal antibody against serotype A and C lipooligosaccharides from Moraxella catarrhalis.
    Hu WG; Chen J; McMichael JC; Gu XX
    Infect Immun; 2001 Mar; 69(3):1358-63. PubMed ID: 11179299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of clearance of bacteria from murine lungs by immunization with detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins.
    Hu WG; Chen J; Battey JF; Gu XX
    Infect Immun; 2000 Sep; 68(9):4980-5. PubMed ID: 10948114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and immunological characteristics of lipooligosaccharide-based conjugate vaccines for serotype C Moraxella catarrhalis.
    Yu S; Gu XX
    Infect Immun; 2007 Jun; 75(6):2974-80. PubMed ID: 17371852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a cluster of three glycosyltransferase enzymes essential for Moraxella catarrhalis lipooligosaccharide assembly.
    Edwards KJ; Allen S; Gibson BW; Campagnari AA
    J Bacteriol; 2005 May; 187(9):2939-47. PubMed ID: 15838019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of different moieties from the lipooligosaccharide molecule in biological activities of the Moraxella catarrhalis outer membrane.
    Peng D; Hu WG; Choudhury BP; Muszyński A; Carlson RW; Gu XX
    FEBS J; 2007 Oct; 274(20):5350-9. PubMed ID: 17892485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipooligosaccharide P(k) (Galalpha1-4Galbeta1-4Glc) epitope of moraxella catarrhalis is a factor in resistance to bactericidal activity mediated by normal human serum.
    Zaleski A; Scheffler NK; Densen P; Lee FK; Campagnari AA; Gibson BW; Apicella MA
    Infect Immun; 2000 Sep; 68(9):5261-8. PubMed ID: 10948153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal immunization of the combined lipooligosaccharide conjugates protects mice from the challenges with three serotypes of Moraxella catarrhalis.
    Ren D; Xie H; Zhang W; Hassan F; Petralia RS; Yu S; Lim DJ; Gu XX
    PLoS One; 2011; 6(12):e29553. PubMed ID: 22216312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis.
    Gu XX; Chen J; Barenkamp SJ; Robbins JB; Tsai CM; Lim DJ; Battey J
    Infect Immun; 1998 May; 66(5):1891-7. PubMed ID: 9573066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transferrin binding protein B of Moraxella catarrhalis elicits bactericidal antibodies and is a potential vaccine antigen.
    Myers LE; Yang YP; Du RP; Wang Q; Harkness RE; Schryvers AB; Klein MH; Loosmore SM
    Infect Immun; 1998 Sep; 66(9):4183-92. PubMed ID: 9712766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hag mutant of Moraxella catarrhalis strain O35E is deficient in hemagglutination, autoagglutination, and immunoglobulin D-binding activities.
    Pearson MM; Lafontaine ER; Wagner NJ; St Geme JW; Hansen EJ
    Infect Immun; 2002 Aug; 70(8):4523-33. PubMed ID: 12117964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of Moraxella catarrhalis outer membrane proteins, CD and UspA, as new carriers for lipooligosaccharide-based conjugates.
    Hu WG; Berry J; Chen J; Gu XX
    FEMS Immunol Med Microbiol; 2004 Jun; 41(2):109-15. PubMed ID: 15145454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipooligosaccharide conjugate vaccine.
    Jiao X; Hirano T; Hou Y; Gu XX
    Infect Immun; 2002 Nov; 70(11):5982-9. PubMed ID: 12379673
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Tzeng YL; Sannigrahi S; Borrow R; Stephens DS
    Front Immunol; 2024; 15():1350344. PubMed ID: 38440731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of an isogenic mutant constructed in Moraxella catarrhalis To identify a protective epitope of outer membrane protein B1 defined by monoclonal antibody 11C6.
    Luke NR; Russo TA; Luther N; Campagnari AA
    Infect Immun; 1999 Feb; 67(2):681-7. PubMed ID: 9916077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.